New In-Body CAR-T therapy takes on Hard-to-Treat myeloma
NCT ID NCT07322159
First seen Jan 09, 2026 · Last updated May 24, 2026 · Updated 22 times
Summary
This early study tests a new treatment called IASO206 for people with multiple myeloma that has come back or stopped responding to other therapies. The treatment uses a special type of cell therapy that works inside the body to attack cancer cells. The main goals are to check if it is safe and to see if it can shrink tumors. About 12 adults aged 18 to 75 will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.